ArticleCells2020
Selinexor Sensitizes TRAIL-R2-Positive TNBC Cells to the Activity of TRAIL-R2xCD3 Bispecific Antibody.
Silvia Martini et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it
ArticleCells2020
Silvia Martini et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.